Skip to content
Whale Atlas — Follow the signal.
Home
FULL RECORDS
Search insider filingsAll Congress filings
MORE TOOLS
WatchlistGold IntelligencePeopleCharts & technicalsCompany financialsOfficial newsMy saved workspace
YOUR RESEARCH
HomeSearch insider filingsAll Congress filings
More research tools
ExploreGold IntelligencePeopleInvestigate an ideaCharts & technicalsMore evidenceCompany financialsOfficial newsMy research & helpWatchlistMy saved workspaceLearn the basicsHow signals workData & coverage
RESOURCES
LearnMethodologyData sources
Built on public evidence.

Primary sources. Clear reasoning.
No black boxes.

Our approach
Public research workspacev1.0

Loading data…Scanning SEC filings…Checking Congress reports…Following the signal…

HomeSearchCongressWatchlist
© 2026 Whale AtlasFree public-filing research. Not financial advice. By using this site you agree to the Terms of Use.
FAQCompare trackersMethodologyData & correctionsTermsPrivacy
Back to Home
I

INBX

Nasdaq

Inhibrx Biosciences, Inc.

Latest disclosureSeptember 28, 2026
Insider score Why 80?
80/ 100
Qualifying buys · 30d
$5.5M

14 purchases · 5 sales

Price by TradingViewDelayed quote from TradingView, for viewing only. It does not power Whale Atlas scores or alerts. If the quote does not load, open the TradingView link.

Insider transactions 28

Limited filing history
All28Buying14Selling5Other9
Filters

Last 30 daysInsiders bought $5.5M · 3 buyers, led by Mark Lappe (CEO) with $3.64M. Sales: $279.01K by 1 insider.

9 of 28 trades · April 24, 2026 – September 28, 2026Incomplete history: this shows the filings imported so far, not every filing ever made. Dates are trade dates. Filters affect this table only.

Showing the first 6 of 9 trades on this page.

Award disclosedAmended filing

Douglas Forsyth

Director

Amended

Related filings are retained as evidence. This economic transaction is counted once.

This amendment supersedes the related original transaction.

Original SEC filing ↗Amended SEC filing ↗

Stock Option (right to buy)

Derivative security · not the ordinary share price.

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded June 3, 2026Filed September 18, 2026SEC filing
Award disclosedAmended filing

Kristiina MD Vuori

Director

Amended

Related filings are retained as evidence. This economic transaction is counted once.

This amendment supersedes the related original transaction.

Original SEC filing ↗Amended SEC filing ↗

Stock Option (right to buy)

Derivative security · not the ordinary share price.

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded June 3, 2026Filed September 18, 2026SEC filing
Award disclosedAmended filing

Kimberly Manhard

Director

Amended

Related filings are retained as evidence. This economic transaction is counted once.

This amendment supersedes the related original transaction.

Original SEC filing ↗Amended SEC filing ↗

Stock Option (right to buy)

Derivative security · not the ordinary share price.

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded June 3, 2026Filed September 18, 2026SEC filing
Award disclosedAmended filing

Jon Faiz Kayyem

Director

Amended

Related filings are retained as evidence. This economic transaction is counted once.

This amendment supersedes the related original transaction.

Original SEC filing ↗Amended SEC filing ↗

Stock Option (right to buy)

Derivative security · not the ordinary share price.

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded June 3, 2026Filed September 18, 2026SEC filing
Award disclosed

Kristiina MD Vuori

Director

Superseded by later filing

Related filings are retained as evidence. This economic transaction is counted once.

This original record remains available as evidence. The later filing replaces it in totals and buying signals.

Superseding SEC filing ↗Original transaction filing ↗

Stock Option (right to buy)

Derivative security · not the ordinary share price.

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded June 3, 2026Filed June 4, 2026SEC filing
Award disclosed

Jon Faiz Kayyem

Director

Superseded by later filing

Related filings are retained as evidence. This economic transaction is counted once.

This original record remains available as evidence. The later filing replaces it in totals and buying signals.

Superseding SEC filing ↗Original transaction filing ↗

Stock Option (right to buy)

Derivative security · not the ordinary share price.

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded June 3, 2026Filed June 4, 2026SEC filing
Award disclosed

Douglas Forsyth

Director

Superseded by later filing

Related filings are retained as evidence. This economic transaction is counted once.

This original record remains available as evidence. The later filing replaces it in totals and buying signals.

Superseding SEC filing ↗Original transaction filing ↗

Stock Option (right to buy)

Derivative security · not the ordinary share price.

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded June 3, 2026Filed June 4, 2026SEC filing
Award disclosed

Kimberly Manhard

Director

Superseded by later filing

Related filings are retained as evidence. This economic transaction is counted once.

This original record remains available as evidence. The later filing replaces it in totals and buying signals.

Superseding SEC filing ↗Original transaction filing ↗

Stock Option (right to buy)

Derivative security · not the ordinary share price.

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded June 3, 2026Filed June 4, 2026SEC filing
Award disclosed

David Matly

President

Stock Option (right to buy)

Derivative security · not the ordinary share price.

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded April 24, 2026Filed April 27, 2026SEC filing
Reporting insiderSecurity / transactionAmount / priceValueTraded / disclosedSource
Director
Amended

Related filings are retained as evidence. This economic transaction is counted once.

This amendment supersedes the related original transaction.

Original SEC filing ↗Amended SEC filing ↗
Stock Option (right to buy)Grant or awardDerivative units10,000Award · no purchase priceNon-cash awardJun 3Filed Sep 18 · 107d laterSEC filing
Director
Amended

Related filings are retained as evidence. This economic transaction is counted once.

This amendment supersedes the related original transaction.

Original SEC filing ↗Amended SEC filing ↗
Stock Option (right to buy)Grant or awardDerivative units10,000Award · no purchase priceNon-cash awardJun 3Filed Sep 18 · 107d laterSEC filing
Director
Amended

Related filings are retained as evidence. This economic transaction is counted once.

This amendment supersedes the related original transaction.

Original SEC filing ↗Amended SEC filing ↗
Stock Option (right to buy)Grant or awardDerivative units10,000Award · no purchase priceNon-cash awardJun 3Filed Sep 18 · 107d laterSEC filing
Director
Amended

Related filings are retained as evidence. This economic transaction is counted once.

This amendment supersedes the related original transaction.

Original SEC filing ↗Amended SEC filing ↗
Stock Option (right to buy)Grant or awardDerivative units10,000Award · no purchase priceNon-cash awardJun 3Filed Sep 18 · 107d laterSEC filing
Director
Superseded by later filing

Related filings are retained as evidence. This economic transaction is counted once.

This original record remains available as evidence. The later filing replaces it in totals and buying signals.

Superseding SEC filing ↗Original transaction filing ↗
Stock Option (right to buy)Grant or awardDerivative units15,000Award · no purchase priceNon-cash awardJun 3Filed Jun 4 · 1d laterSEC filing
Director
Superseded by later filing

Related filings are retained as evidence. This economic transaction is counted once.

This original record remains available as evidence. The later filing replaces it in totals and buying signals.

Superseding SEC filing ↗Original transaction filing ↗
Stock Option (right to buy)Grant or awardDerivative units15,000Award · no purchase priceNon-cash awardJun 3Filed Jun 4 · 1d laterSEC filing
Director
Superseded by later filing

Related filings are retained as evidence. This economic transaction is counted once.

This original record remains available as evidence. The later filing replaces it in totals and buying signals.

Superseding SEC filing ↗Original transaction filing ↗
Stock Option (right to buy)Grant or awardDerivative units15,000Award · no purchase priceNon-cash awardJun 3Filed Jun 4 · 1d laterSEC filing
Director
Superseded by later filing

Related filings are retained as evidence. This economic transaction is counted once.

This original record remains available as evidence. The later filing replaces it in totals and buying signals.

Superseding SEC filing ↗Original transaction filing ↗
Stock Option (right to buy)Grant or awardDerivative units15,000Award · no purchase priceNon-cash awardJun 3Filed Jun 4 · 1d laterSEC filing
PresidentStock Option (right to buy)Grant or awardDerivative units50,000Award · no purchase priceNon-cash awardApr 24Filed Apr 27 · 3d laterSEC filing

Congress transactions 0

All Congress filings
No disclosed congressional trades for INBX in the imported filings.

This reflects the filings imported so far, not a complete trading history.

Explore furtherTechnical lab Company financials Test a strategy Compare company

Why this buying score?

Qualifying common-equity purchase value

$5,098,421 of common-equity purchase value after transaction-age decay across 180 days.

+25 pts

Distinct buying groups

3 distinct reporting-owner group(s). Joint rows count once; identity is not proof of discretion.

+20 pts

CEO purchase

Qualifying common-equity P acquisition; no disclosed plan, exercise or excluded purchase context detected.

+15 pts

Insider buying cluster

3 buying groups inside 30 transaction-date days, public by the snapshot cutoff.

+15 pts

Repeated purchases

A reporting-owner group bought on at least two distinct dates within the cluster window.

+5 pts

This score describes qualifying insider purchases at issuer level. Read the methodology

Sources and coverage

Limited filing history · Market-wide discovery does not establish complete company history. View coverage
Source
SEC EDGAR · Form 4
Issuer CIK
0002007919
Latest public acceptance
Sep 28, 2026, 09:47 PM UTC
Score calculated
Oct 7, 2026, 12:12 AM UTC
Parser
form4-parser-1.5
Classifier
form4-classifier-1.1
Scoring methodology
insider-experimental-1.1
Availability
Public filing time, not trade date

Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.

Insider activity can have many explanations. Signal Strength is not a probability of profit or a recommendation to trade.